Letters, calls and emails: Concern over statin switching

Dear Editor

I am concerned with the current drive for switching for several reasons and am writing on a basis of being a predominant simvastatin prescriber.  

This afternoon I saw a man on 10mg of atorvastatin, a cholesterol of 3.8 and an MI 20 years ago at the age of 40, currently ‘well’. If I was him I would not want to be switched. That is the argument at a personal level.  

The NHS agrees a tariff price, I believe, with manufacturers — why, if atorvastatin is too dear is this not sorted centrally?  

However, I am also surprised that the manufacturer does not cut its losses and reduce the price.  

Finally, this needs to be considered with the agenda of research costs. I live and work near a huge pharma research base. This needs funding; if we change everything to the cheapest generic eventually the Western research market will move away which might have even greater risks to the NHS. Bigger NHS savings could be made by abandoning the private finance initiative and amending the current computer programme.  

Dr John Sharvill  

Deal, Kent 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Just published

Young doctor

BMA poll could see 'demeaning' junior doctor title ditched

The BMA could drop the term 'junior doctor' in favour of 'resident doctor' to better...

Houses of parliament

Tory peer calls PA fears 'Luddism' and claims most GP visits 'incredibly straightforward'

Most GP appointments are 'incredibly straightforward' and fears over a wider role...

UK money

NHS pension contribution overhaul to go ahead from April

Changes to NHS pension contribution rates, which will see the top earners required...

BMA sign

BMA warns £800m lost from GP contract since 2019 as last-ditch talks continue

BMA negotiators remain in talks over an improved GP contract offer for 2024/25 just...

GP consultation

GPs still under pressure to prescribe black triangle drug inclisiran

GPs are continuing to face pressure to prescribe the black triangle drug inclisiran...

BMA chair Professor Phil Banfield

Lords urged to block legislation for GMC to regulate PAs

The BMA has urged peers to block legislation that would make the GMC responsible...